Adverse Effects of GLP-1 Receptor Agonists
The Review of Diabetic Studies · 2014 · 11 (3-4) · 202-230
DOI: 10.1900/rds.2014.11.202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Review of Diabetic Studies, 2014. Verfasst von Theodosios D Filippatos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 560-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Zitieren
APA
Filippatos, T. D., Panagiotopoulou, T. V., & Elisaf, M. S. (2014). Adverse Effects of GLP-1 Receptor Agonists. The Review of Diabetic Studies, 11(3-4), 202-230. https://doi.org/10.1900/rds.2014.11.202
Vancouver
Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse Effects of GLP-1 Receptor Agonists. The Review of Diabetic Studies. 2014;11(3-4):202-230. doi:10.1900/rds.2014.11.202
BibTeX
@article{Filippatos2014,
author = {Filippatos, Theodosios D and Panagiotopoulou, Thalia V and Elisaf, Moses S},
title = {Adverse Effects of GLP-1 Receptor Agonists},
journal = {The Review of Diabetic Studies},
year = {2014},
volume = {11},
number = {3-4},
pages = {202--230},
doi = {10.1900/rds.2014.11.202}
}
EUVIMED